0.71
-0.0201 (-2.75%)
-0.0201 (-2.75%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 222,729 |
|
|||||
| News | - | ||||||
| Day High | 0.75 | Low High |
|||||
| Day Low | 0.6787 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0201 | -2.75% | 0.71 | 19:56:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7401 | 0.6787 | 0.75 | 0.6998 | 0.7301 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 633 | 222,729 | $ 0.7188809 | $ 160,116 | - | 0.6101 - 2.3184 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:51:24 | 41 | $ 0.7455 | USD |
Period:
Draw Mode:
Hepion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 54.12M | 76.23M | 76.11M | $ - | $ - | -0.47 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 1.00% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.775 | 0.816 | 0.6101 | 0.7077429 | 349,195 | -0.065 | -8.39% |
| 1 Month | 1.02 | 1.0754 | 0.6101 | 0.8369958 | 276,553 | -0.31 | -30.39% |
| 3 Months | 1.03 | 1.33 | 0.6101 | 1.06 | 311,791 | -0.32 | -31.07% |
| 6 Months | 1.43 | 1.43 | 0.6101 | 1.14 | 505,920 | -0.72 | -50.35% |
| 1 Year | 1.572 | 2.3184 | 0.6101 | 1.61 | 1,040,524 | -0.862 | -54.83% |
| 3 Years | 3.11 | 8.35 | 0.6101 | 2.45 | 1,557,459 | -2.40 | -77.17% |
| 5 Years | 3.11 | 8.35 | 0.6101 | 2.45 | 1,557,459 | -2.40 | -77.17% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |